Balanced news tone
News Sentiment
STTK sentiment intelligence
Shattuck Labs Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
64 relevant articles
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-5.8% over one week, +34.4% over four weeks, trend active, and materially above fair value.
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update - Slideshow (NASDAQ:STTK) 2026-07-08
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
83/100 classification
One-week reaction
-5.8%
Price reacting lower
Trend fit
Trend active
34.4% over four weeks
Fair value
77.8%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
11
Neutral
47
Negative
6
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Industry context
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
Seeking Alpha
Direct company coverage
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update - Slideshow (NASDAQ:STTK) 2026-07-08
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 23:32
- Source
- Seeking Alpha
Investing.com
Direct company coverage
Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock
Shattuck Labs CTO Abhinav Shukla sold 410 shares of company stock worth $2,874 on July 2, 2026, as part of a Rule 10b5-1 trading plan to cover option exercise costs. On the same day and again on July 6, 2026, Mr. Shukla acquired a total of 12,563 shares through stock option exerc
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 21:39
- Source
- Investing.com
Investing.com South Africa
Direct company coverage
Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock By Investing.com
Shattuck Labs CTO Abhinav Shukla sold 410 shares of company stock for $2,874 at a weighted average price of $7.01, pursuant to a Rule 10b5-1 trading plan. This sale occurred while the stock was trading near its 52-week high after an 840% gain. Concurrently, Shukla acquired 12,563
- Tone
- Positive 60/100
- Event
- Market update
- Published
- 08 Jul 2026 00:10
- Source
- Investing.com South Africa
Investing.com Nigeria
Direct company coverage
Form 4 Shattuck Labs Inc For: 7 July By Investing.com
Investing.com reported the filing of a Form 4 for Shattuck Labs Inc. on July 7. The brief announcement provides no specific details from the filing, only referencing the company's stock symbol STTK.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 23:10
- Source
- Investing.com Nigeria
Stock Titan
Direct company coverage
Shattuck Labs (STTK) CTO exercises options and makes small 10b5-1 sale
Shattuck Labs' Chief Technical Officer, Abhinav A. Shukla, exercised options to acquire 12,563 shares of common stock at $3.57 per share. To cover the exercise costs and tax withholding, he sold 410 shares of common stock at a weighted average price of $7.01 under a pre-arranged
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 23:10
- Source
- Stock Titan
AD HOC NEWS
Direct company coverage
Shattuck Labs outlines its oncology platform as investors assess long-term prospects
Shattuck Labs, a clinical-stage biotechnology company, is focused on developing novel immunotherapies for cancer and autoimmune diseases using its proprietary fusion protein technology. The company pursues a platform strategy designed to modulate immune pathways in the tumor micr
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 13:10
- Source
- AD HOC NEWS
Finviz
Direct company coverage
STTK - Shattuck Labs Inc Options
This page provides a detailed financial overview of Shattuck Labs Inc (STTK), including its last close price, market capitalization, income, sales, and various financial ratios. It also presents key performance indicators such as EPS, sales growth, insider and institutional owner
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jul 2026 14:41
- Source
- Finviz
Ad-hoc-news.de
Direct company coverage
Shattuck Labs focuses on immunotherapy pipeline as investors watch clinical milestones
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 14:50
- Source
- Ad-hoc-news.de
Investing.com
Direct company coverage
Shattuck Labs cmo Pandite sells $210,300 in company stock
Shattuck Labs' Chief Medical Officer, Pandite Arundathy N., sold 30,000 shares of the company's common stock for a total of $210,300 on June 30, 2026. This transaction was conducted under a Rule 10b5-1 trading plan, and Ms. Pandite now directly holds 136,219 shares. The sale occu
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 03 Jul 2026 08:09
- Source
- Investing.com
GuruFocus
Direct company coverage
Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK)
Arundathy Pandite, Chief Medical Officer at Shattuck Labs Inc (STTK), sold 30,000 shares of the company on June 30, 2026, reducing her holdings to 136,219 shares. Over the past year, Pandite has sold a total of 60,000 shares, with no purchases. The stock, trading at $7.01, is con
- Tone
- Negative 29/100
- Event
- Market update
- Published
- 03 Jul 2026 04:10
- Source
- GuruFocus
Investing.com
Direct company coverage
Abhinav Shukla, Shattuck Labs CTO, sells $166,131 in stock
Abhinav Shukla, CTO of Shattuck Labs (NASDAQ: STTK), sold $166,131 worth of company stock across two transactions on June 30 and July 1, 2026, after exercising options. These sales were part of a Rule 10b5-1 trading plan to cover exercise prices and taxes. Despite a 746% stock in
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 01:10
- Source
- Investing.com
Stock Titan
Direct company coverage
Shattuck Labs (NASDAQ: STTK) CTO option exercises and 23,465-share sale disclosed
Shattuck Labs CTO Abhinav A. Shukla reported exercising stock options for 23,465 shares at $3.57 each and simultaneously selling the same number of shares on the open market at weighted average prices of approximately $7.08 and $7.07 per share. These transactions, conducted under
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 00:10
- Source
- Stock Titan
Stock Titan
Direct company coverage
Shattuck Labs (STTK) CMO sells 30,000 shares under 10b5-1 plan
Shattuck Labs' Chief Medical Officer, Arundathy N. Pandite, sold 30,000 shares of common stock at a weighted average price of $7.01 per share. This transaction occurred on June 30, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted on February 2, 2026. Following the sale
- Tone
- Negative 37/100
- Event
- Market update
- Published
- 03 Jul 2026 00:10
- Source
- Stock Titan
Stock Titan
Direct company coverage
410-share sale reported by STTK insider (NASDAQ: STTK) via option exercise
An insider of Shattuck Labs, Inc. (NASDAQ: STTK) has reported a proposed sale of 410 shares of Common Stock through a stock option exercise, to be sold for cash on July 2, 2026, with Fidelity Brokerage Services LLC listed as the broker. The SEC filing (Form 144) also details prio
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 02 Jul 2026 20:10
- Source
- Stock Titan
Investing.com Nigeria
Direct company coverage
Form 144 Shattuck Labs For: 1 July By Investing.com
This article reports on a Form 144 filing by Shattuck Labs (STTK) for July 1. Form 144 filings indicate an affiliate's intent to sell restricted securities. The article provides the date of the filing and mentions a stock performance of +8.29% for STTK, as well as current market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:39
- Source
- Investing.com Nigeria
Stock Titan
Direct company coverage
Abhinav A. Shukla (STTK) files to sell 100 common shares via Form 144
Abhinav A. Shukla has filed a Form 144 notice to sell 100 common shares of Shattuck Labs, Inc. (STTK), acquired through a stock option exercise. The filing, dated July 1, 2026, also details previous sales in May and June 2026 totaling 25,397 shares for combined proceeds of over $
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 20:39
- Source
- Stock Titan
Investing.com Canada
Direct company coverage
Form 144 Shattuck Labs For: 30 June By Investing.com
This article from Investing.com is a brief report stating that Shattuck Labs (STTK) filed a Form 144 for the period ending June 30. The article indicates a slight increase in the company's stock price by 1.31% at the time of publication and is part of a series of financial news u
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 20:10
- Source
- Investing.com Canada
Stock Titan
Direct company coverage
STTK (NASDAQ) files Rule 144 notice for stock-option sale on 06/30/2026
Shattuck Labs, Inc. (STTK) has filed a Rule 144 notice indicating an intended sale of Common stock related to a Stock Option Exercise with a transaction date of June 30, 2026. The filing specifies Fidelity Brokerage Services LLC as the broker involved and notes cash as the consid
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 30 Jun 2026 20:10
- Source
- Stock Titan
www.marketscreener.com
Direct company coverage
Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell 2000 Index
Shattuck Labs, Inc. (NasdaqGS: STTK), a biotechnology company focused on treatments for inflammatory and immune-mediated diseases, has been added to the Russell 2000 Index. This inclusion means the company's stock will now be part of several Russell indices, including the Russell
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 29 Jun 2026 19:10
- Source
- www.marketscreener.com
www.marketscreener.com
Direct company coverage
Shattuck Labs, Inc.(NasdaqGS:STTK) added to Russell Small Cap Comp Growth Benchmark
Shattuck Labs, Inc. (NasdaqGS:STTK) has been added to the Russell Small Cap Comp Growth Benchmark, alongside several other Russell indices including the Russell 2500 Growth, Russell 2000, and Russell Microcap Growth benchmarks. This inclusion highlights the company's growing pres
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 29 Jun 2026 17:12
- Source
- www.marketscreener.com
TradingView
Direct company coverage
Price to sales forward of Shattuck Labs, Inc. – NASDAQ:STTK
This article provides financial information for Shattuck Labs, Inc. (NASDAQ: STTK). It lists the forward price-to-sales ratio and notes that the market is currently closed with no trades. The content primarily shows navigation elements and links related to financial data and anal
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 18:10
- Source
- TradingView
TradingView
Direct company coverage
Enterprise value to EBIT forward of Shattuck Labs, Inc. – NASDAQ:STTK
This article provides the enterprise value to EBIT forward for Shattuck Labs, Inc. (NASDAQ:STTK) as displayed on TradingView. It indicates that the market for STTK was closed at the time of viewing and presents various navigation options related to financial data, news, and commu
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 11:09
- Source
- TradingView
TradingView
Direct company coverage
Price to earnings forward of Shattuck Labs, Inc. – NASDAQ:STTK
This article provides the "Price to earnings forward" value for Shattuck Labs, Inc. (NASDAQ: STTK) on TradingView. It indicates that the market is closed, and no trades have occurred for the company. The content focuses on financial data provided by various sources like ICE Data
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 00:41
- Source
- TradingView
TradingView
Direct company coverage
Shattuck Labs, Inc. Actuals & Estimates (NASDAQ:STTK)
This article provides an overview of Shattuck Labs, Inc. (NASDAQ:STTK) stock, including its current price, historical performance, analyst forecasts, and financial data. It highlights the stock's recent price increase, its market capitalization, and upcoming earnings report. The
- Tone
- Positive 70/100
- Event
- Earnings
- Published
- 25 Jun 2026 19:41
- Source
- TradingView
Moomoo
Direct company coverage
Citi Upgrades Shattuck Labs(STTK.US) to Buy Rating, Maintains Target Price $7
Citi has upgraded Shattuck Labs (STTK.US) to a Buy rating. The firm has also chosen to maintain its target price for the company at $7.
- Tone
- Positive 73/100
- Event
- Analyst action
- Published
- 20 Jun 2026 14:40
- Source
- Moomoo
MSN
Direct company coverage
Shattuck Labs drops 6%, prices $75M share raise at $4 per share
Shattuck Labs (STTK) saw its shares drop 6% after announcing the pricing of its previously announced upsized public offering. The company will sell 18,750,000 shares of its common stock at a price of $4.00 per share, aiming to raise $75 million. The offering is expected to close
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 20 Jun 2026 13:40
- Source
- MSN
GuruFocus
Direct company coverage
Orbimed Advisors LLC Increases Stake in Shattuck Labs Inc
Orbimed Advisors LLC has increased its stake in Shattuck Labs Inc (STTK) by acquiring an additional 2,715,000 shares, bringing its total holdings to over 9 million shares. This strategic move, executed at $4.18 per share, signifies Orbimed's confidence in the biotechnology compan
- Tone
- Positive 63/100
- Event
- Deals and strategy
- Published
- 20 Jun 2026 01:10
- Source
- GuruFocus
TradingKey
Direct company coverage
Shattuck Labs Inc (STTK) Institutional Confidence
The article provides an overview of Shattuck Labs Inc (STTK)'s institutional confidence score, shareholding proportion, and key institutional shareholders. The company has an institutional shareholding score of 5.00, ranking 133 out of 388 in its industry, with 65.78% of shares h
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 18 Jun 2026 10:39
- Source
- TradingKey
TradingKey
Direct company coverage
Shattuck Labs Inc (STTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Shattuck Labs Inc (STTK), detailing its current price momentum score, identified support and resistance levels, and a comprehensive breakdown of various technical indicators and moving averages. While the stock is trading between resi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 09:38
- Source
- TradingKey